Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
|
J Pharmacol Exp Ther
|
2007
|
1.29
|
2
|
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents.
|
FASEB J
|
2010
|
1.12
|
3
|
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
|
J Biol Chem
|
2007
|
1.08
|
4
|
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.
|
J Med Chem
|
2005
|
1.07
|
5
|
CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
|
J Alzheimers Dis
|
2010
|
0.96
|
6
|
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer.
|
Thorax
|
2011
|
0.96
|
7
|
The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice.
|
J Alzheimers Dis
|
2011
|
0.95
|
8
|
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.
|
BMC Neurosci
|
2013
|
0.92
|
9
|
In vivo imaging of transiently transgenized mice with a bovine interleukin 8 (CXCL8) promoter/luciferase reporter construct.
|
PLoS One
|
2012
|
0.90
|
10
|
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).
|
J Med Chem
|
2006
|
0.88
|
11
|
In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
|
Pharmacol Res
|
2007
|
0.87
|
12
|
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.
|
Neuroreport
|
2002
|
0.86
|
13
|
Enlightened Mannhemia haemolytica lung inflammation in bovinized mice.
|
Vet Res
|
2014
|
0.83
|
14
|
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice.
|
Am J Alzheimers Dis Other Demen
|
2004
|
0.83
|
15
|
Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology.
|
MAGMA
|
2010
|
0.80
|
16
|
Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung.
|
Pharmacol Res
|
2007
|
0.79
|
17
|
Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice.
|
Am J Respir Cell Mol Biol
|
2012
|
0.79
|
18
|
Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.
|
Prion
|
2012
|
0.77
|
19
|
CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats.
|
Eur J Pharmacol
|
2005
|
0.77
|
20
|
Mechanisms of action of CHF3381 in the forebrain.
|
Br J Pharmacol
|
2003
|
0.77
|
21
|
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.
|
J Med Chem
|
2014
|
0.76
|
22
|
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
|
J Med Chem
|
2007
|
0.76
|
23
|
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
|
J Med Chem
|
2007
|
0.76
|
24
|
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.
|
Bioorg Med Chem
|
2006
|
0.76
|
25
|
The protective effect of ganstigmine against amyloid beta 25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition.
|
Neurosci Lett
|
2003
|
0.75
|
26
|
Discovery and optimization of thiazolidinyl- and pyrrolidinyl- derivatives as inhaled PDE4 inhibitors for respiratory diseases.
|
J Med Chem
|
2017
|
0.75
|
27
|
High throughput screening of beta-amyloid secretion inhibitors using homogenous time-resolved fluorescence.
|
Comb Chem High Throughput Screen
|
2004
|
0.75
|